PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report)’s stock price traded up 8.3% during trading on Thursday . The stock traded as high as $1.82 and last traded at $1.82. 9,226 shares changed hands during mid-day trading, an increase of 4% from the average session volume of 8,831 shares. The stock had previously closed at $1.68.
PharmaCyte Biotech Stock Performance
The business’s 50 day moving average price is $1.85 and its two-hundred day moving average price is $2.05.
PharmaCyte Biotech Company Profile
PharmaCyte Biotech, Inc is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
Further Reading
- Five stocks we like better than PharmaCyte Biotech
- Most Volatile Stocks, What Investors Need to Know
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- Health Care Stocks Explained: Why You Might Want to Invest
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
- Canada Bond Market Holiday: How to Invest and Trade
- MarketBeat Week in Review – 9/9 – 9/13
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
